content: <HTML>
  <HEAD>
  <TITLE></TITLE>
  </HEAD>
  <BODY STYLE="font-size: 10pt">
  
  
  <P STYLE="margin: 0; text-align: center"><B>UNITED STATES</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>Washington, D.C. 20549</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>FORM 8-K</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>CURRENT REPORT</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>Pursuant to Section 13 or 15(d) of the Securities
  Exchange Act of 1934</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center">Date of Report (Date of the earliest event
  reported):&nbsp;&nbsp;September 1, 2015</P>
  
  <P STYLE="margin: 0; text-align: center"><B>&nbsp;</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>Cloud Medical Doctor Software Corporation</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B></B>&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center">(Exact name of registrant as specified in its
  charter)</P>
  
  <P STYLE="margin: 0; text-align: center">(formerly National Scientific Corporation)</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="width: 34%; border-bottom: black 1pt solid; font-size: 10pt; text-align: center"><B>Texas</B></TD>
      <TD STYLE="width: 33%; border-bottom: black 1pt solid; font-size: 10pt; text-align: center"><B>000-28745</B></TD>
      <TD STYLE="width: 33%; border-bottom: black 1pt solid; font-size: 10pt; text-align: center"><B>86-0837077</B></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(State or other jurisdiction</P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">of incorporation or organization)</P></TD>
      <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(Commission</P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">File Number)</P></TD>
      <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">(I.R.S. Employer</P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Identification No.)</P></TD></TR>
  </TABLE>
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;&nbsp;<B>1291 Galleria Drive, Suite 200</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>Henderson, NV 89014</B>&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>(Address of principal executive offices)
  (Zip Code)</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>&nbsp;</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>702-818-9011</B></P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  
  
  <P STYLE="margin: 0; text-align: center">Registrant&rsquo;s telephone number, including area code</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">Check the appropriate box below if the Form
  8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">[ ] Written communications pursuant to Rule
  425 under the Securities Act (17 CFR 230.425)</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">[ ] Soliciting material pursuant to Rule 14a-12
  under the Exchange Act (17 CFR 240.14a-12)</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">[ ] Pre-commencement communications pursuant
  to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">[ ] Pre-commencement communications pursuant
  to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))&nbsp;</P>
  
  
  <!-- Field: Page; Sequence: 1 -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>
  
  <P STYLE="margin: 0; text-align: justify"><B>Section 5 - Corporate Governance and Management</B></P>
  
  <P STYLE="margin: 0; text-align: justify"><B>&nbsp;</B></P>
  
  <P STYLE="margin: 0; text-align: justify"><B>Item 5.02. Departure of Directors
  or Principal Officers; Election of Directors; Appointment of Principal Officers</B></P>
  
  <P STYLE="margin: 0; text-align: justify"><B>&nbsp;</B></P>
  
  <P STYLE="margin: 0; text-align: justify">On September 1, 2015 Albert Carlson PhD was appointed Chief Scientist
  of the Company. Dr. Carlson shall oversee the development of the Company&rsquo;s CiperLoc&reg; Suite of products and report directly
  to the President/CEO.</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">Dr. Carlson created and led teams advancing the state-of-the-art
  in more than six embedded, computer, and electrical engineering sectors, creating new markets, products, and value for exploitation.
  He has extensive experience in on-time design to delivery while remaining under budget at all levels of engineering. Additionally,
  he has worked in many areas of engineering and has focused extensive world knowledge, as well as deep algorithmic, set theory,
  mathematical, and design expertise. Dr. Carlson is 56 years old and holds a PhD in Computer Science from the university of Idaho.</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">There are no transactions involving the newly appointed Chief Scientist
  that are reportable under Item 404(a) of Regulation S-K for the purposes of this Current Report on Form 8-K.</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><B>Item 9.01 Financial Statements and Exhibits</B></P>
  
  <P STYLE="margin: 0; text-align: justify"><B>&nbsp;</B></P>
  
  <TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0; margin-bottom: 6pt"><TR STYLE="vertical-align: top; text-align: justify">
  <TD STYLE="width: 55pt; text-align: right">Exhibit 10.15</TD><TD STYLE="width: 5pt"></TD><TD STYLE="text-align: justify"><A HREF="clok8k090415ex10_15.htm">Employment Agreement Dr. Albert Carlson</A></TD>
  </TR></TABLE>
  
  
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <!-- Field: Page; Sequence: 2 -->
      <DIV STYLE="margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin: 0; text-align: justify"></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURES</B></P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of Section 13
  or 15(d) of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned,
  thereunto duly authorized.</P>
  
  <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
      <TD STYLE="width: 23%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Registrant</P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Date: January 8, 2014</P></TD>
      <TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
      <TD STYLE="width: 76%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>Cloud Medical Doctor Software Corporation</I></P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><I>&nbsp;</I></P>
          <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><I>By:&nbsp;<U>/s/ Michael De La Garza</U></I></P></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="font-size: 10pt">&nbsp;</TD>
      <TD STYLE="background-color: white; font-size: 10pt; text-align: justify">Michael De La Garza</TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD>
      <TD STYLE="font-size: 10pt">&nbsp;</TD>
      <TD STYLE="background-color: white; font-size: 10pt; text-align: justify">Chief Executive Officer (Principal Executive Officer)
      and Director</TD></TR>
  </TABLE>
  
  <P STYLE="margin-top: 0; margin-bottom: 0"></P>
  
  <!-- Field: Page; Sequence: 3; Options: Last -->
      <DIV STYLE="margin-bottom: 6pt"><P STYLE="margin: 0pt"></P></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
  </BODY>
  </HTML>
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "clok8k090415.htm", "secsgml_size_bytes": 10038}]
metadata_filer: {"company-data": {"conformed-name": "CIPHERLOC Corp", "cik": "0001022505", "assigned-sic": "7374", "irs-number": "860837077", "state-of-incorporation": "TX", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-28745", "film-number": "151094653"}, "business-address": {"street1": "1291 GALLERIA DRIVE", "street2": "SUITE 200", "city": "HENDERSON", "state": "NV", "zip": "89014", "phone": "702-818-9011"}, "mail-address": {"street1": "1291 GALLERIA DRIVE", "street2": "SUITE 200", "city": "HENDERSON", "state": "NV", "zip": "89014"}, "former-company": {"former-conformed-name": "NATIONAL SCIENTIFIC CORP/AZ", "date-changed": "19991229"}}
text: UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION
  Washington, D.C. 20549
  FORM 8-K
  CURRENT REPORT
  Pursuant to Section 13 or 15(d) of the Securities
  Exchange Act of 1934
  Date of Report (Date of the earliest event
  reported):  September 1, 2015
  Cloud Medical Doctor Software Corporation
  (Exact name of registrant as specified in its
  charter)
  (formerly National Scientific Corporation)
  Texas
  000-28745
  86-0837077
  (State or other jurisdiction
  of incorporation or organization)
  (Commission
  File Number)
  (I.R.S. Employer
  Identification No.)
  1291 Galleria Drive, Suite 200
  Henderson, NV 89014
  (Address of principal executive offices)
  (Zip Code)
  702-818-9011
  Registrant's telephone number, including area code
  Check the appropriate box below if the Form
  8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
  [ ] Written communications pursuant to Rule
  425 under the Securities Act (17 CFR 230.425)
  [ ] Soliciting material pursuant to Rule 14a-12
  under the Exchange Act (17 CFR 240.14a-12)
  [ ] Pre-commencement communications pursuant
  to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  [ ] Pre-commencement communications pursuant
  to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
  Section 5 - Corporate Governance and Management
  Item 5.02. Departure of Directors
  or Principal Officers; Election of Directors; Appointment of Principal Officers
  On September 1, 2015 Albert Carlson PhD was appointed Chief Scientist
  of the Company. Dr. Carlson shall oversee the development of the Company's CiperLoc® Suite of products and report directly
  to the President/CEO.
  Dr. Carlson created and led teams advancing the state-of-the-art
  in more than six embedded, computer, and electrical engineering sectors, creating new markets, products, and value for exploitation.
  He has extensive experience in on-time design to delivery while remaining under budget at all levels of engineering. Additionally,
  he has worked in many areas of engineering and has focused extensive world knowledge, as well as deep algorithmic, set theory,
  mathematical, and design expertise. Dr. Carlson is 56 years old and holds a PhD in Computer Science from the university of Idaho.
  There are no transactions involving the newly appointed Chief Scientist
  that are reportable under Item 404(a) of Regulation S-K for the purposes of this Current Report on Form 8-K.
  Item 9.01 Financial Statements and Exhibits
  Exhibit 10.15
  Employment Agreement Dr. Albert Carlson
  SIGNATURES
  Pursuant to the requirements of Section 13
  or 15(d) of the Securities Exchange Act of 1934 the registrant has duly caused this report to be signed on its behalf by the undersigned,
  thereunto duly authorized.
  Registrant
  Date: January 8, 2014
  Cloud Medical Doctor Software Corporation
  By:
  /s/ Michael De La Garza
  Michael De La Garza
  Chief Executive Officer (Principal Executive Officer)
      and Director